Kittm1.1Gnf
Targeted Allele Detail
|
|
| Symbol: |
Kittm1.1Gnf |
| Name: |
Kit proto-oncogene receptor tyrosine kinase; targeted mutation 1.1, Genomics Institute of the Novartis Research Foundation |
| MGI ID: |
MGI:5620943 |
| Synonyms: |
KitT670I |
| Gene: |
Kit Location: Chr5:75735647-75817382 bp, + strand Genetic Position: Chr5, 39.55 cM
|
| Alliance: |
Kittm1.1Gnf page
|
|
| Germline Transmission: |
Earliest citation of germline transmission:
J:211930
|
| Parent Cell Line: |
Bruce 4 (ES Cell)
|
| Strain of Origin: |
B6.Cg-Thy1a
|
|
| Allele Type: |
|
Targeted (Not Specified) |
| Mutations: |
|
Insertion, Single point mutation
|
| |
|
Mutation details: A targeting construct introduced a C to T point mutation in exon 14 that results in the amino acid substitution of isoleucine for threonine at position 670 (T607I). Flp-mediated recombination removed an FRT-flanked neomycin resistance cassette with a 3' loxP site introduced downstream of the modified exon 14.
(J:211930)
|
|
Generation of the Kittm1.1Gnf allele |
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Kit Mutation: |
177 strains or lines available
|
|
| Original: |
J:211930 Lau J, et al., Inhibition of c-Kit is not required for reversal of hyperglycemia by imatinib in NOD mice. PLoS One. 2014;9(1):e84900 |
| All: |
1 reference(s) |
|